HIGHLIGHTS
- who: Jia Liu and Guang Wang from the China Medical University, China have published the research: Different Interactive Effects of Metformin and Acarbose With Dietary Macronutrient Intakes on Patients With Type 2 Diabetes Mellitus: Novel Findings From the MARCH Randomized Trial in China, in the Journal: (JOURNAL)
- what: The trial showed that acarbose has a similar efficacy to metformin, making it a viable option for Chinese patients. The results of this study have shown that the daily intake of total energy, carbohydrates, protein, and fat for included newly diagnosed patients with T2DM fell into the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.